12 Health Care Stocks Moving In Friday's Intraday Session
Gainers
Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 24.6% to $6.42 during Friday's regular session. The company's market cap stands at $10.3 million.
Aethlon Medical (NASDAQ:AEMD) shares moved upwards byread more...
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers
Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 41.4% to $7.29 during Friday's pre-market session. The company's market cap stands at $10.3 million.
Aethlon Medical (NASDAQ:AEMD) stock moved upwards byread more...
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers
Aethlon Medical (NASDAQ:AEMD) stock rose 50.7% to $3.27 during Thursday's after-market session. The market value of their outstanding shares is at $1.6 million.
Modular Medical (NASDAQ:MODD) stock roseread more...
Benzinga
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier Program
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier Program Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier Program PR Newswire SAN DIEGO, Aug. 13, 2026 Conference Call Today at 4:30 p.m. ETSAN DIEGO, Aug. 13, 2026 /PRNewswire/ -- Aethlon Medical...
PR Newswire
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026 Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026 PR Newswire SAN DIEGO, Aug. 5, 2026 SAN DIEGO, Aug. 5, 2026 /PRNewswire/ -- Aethlon Medical...
PR Newswire
Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier
Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier PR Newswire SAN DIEGO, July...
PR Newswire
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules PR Newswire SAN DIEGO, July 6, 2026 SAN DIEGO, July 6, 2026 /PRNewswire...
PR Newswire
Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier
Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier PR Newswire SAN DIEGO, June 26...
PR Newswire
Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update PR Newswire SAN DIEGO, June 10, 2026 Australian oncology study advances into Cohort 3 as enrollment...
PR Newswire
The Next Meme Stock Wave?
A fresh wave of speculative activity swept through the small-cap market this week as traders piled into a combination of AI-linked companies, China-based growth stories, and emerging defense contractors. $BLIS, $GMM, $PAVS, $AEMD, $PAYO, $AZI, $CGTL, $CCSC, $ELPW, $JZXN, $MTEN
24-7 Market News